AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05063266 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deep Breathing Exercise
Description: control groups received deep breathing exercise 6 days a week for two weeks. Deep breathing exercises includes diaphragmatic breathing and pursed lip breathing.
Study NCT05063266 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle Training
Description: Treatment group received inspiratory muscle training 20 minutes 6 days a week for two weeks.IMT was done by using pressure threshold device.
Study NCT00316693 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HPV-16/18 vaccine (Cervarix™)
Description: Intramuscular injection, 3 doses
Study NCT00311623 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Description: Radical prostatectomy performed on Day 15
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: biphasic insulin aspart
Description: Treat-to-target dose titration scheme. The titration scheme is based on the previous 3 days fasting plasma glucose (FPG) measurements.
Study NCT00316693 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Aimmugen™
Description: Intramuscular injection, 3 doses
Study NCT00871039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Patients to be sedated for up to 72 hours with study drug propofol
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin glargine
Description: Treat-to-target dose titration scheme. The titration scheme is based on the previous 3 days fasting plasma glucose (FPG) measurements.
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: metformin
Description: Tablets, 2550 mcg. Administered once daily.
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: Tablets, 2550 mcg. Administered once daily.
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: glimepiride
Description: Tablets 2 mg. 4, 6 or 8 mg administered once daily.
Study NCT00469092 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: glimepiride
Description: Tablets 2 mg. 4, 6 or 8 mg administered once daily.
Study NCT02364544 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Relapse Prevention Plan
Description: brief, in-person, relapse prevention counseling with supplemental web-based learning modules,
Study NCT01435564 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: pedometer only
Description: Participants in this group will receive only a pedometer.
Study NCT01204489 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensified dietary counseling at child wellfare clinics.
Description: The intervention is completed by public health nurses who receive updating education in nutrition. A special training in a family-centred lifestyle counseling method in implemented. The nutrition intervention consists of tailored dietary counseling, information leaflets and self-evaluation card given to the families in the intervention arm. In the control clinics, public health nurses continue their usual dietary counseling.
Study NCT01204489 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intensified dietary counseling at child wellfare clinics.
Description: The intervention is completed by public health nurses who receive updating education in nutrition. A special training in a family-centred lifestyle counseling method in implemented. The nutrition intervention consists of tailored dietary counseling, information leaflets and self-evaluation card given to the families in the intervention arm. In the control clinics, public health nurses continue their usual dietary counseling.
Study NCT02364544 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Daily Support Website
Description: web-based program for patients and families that provides psychoeducation about schizophrenia and its treatments to improve knowledge, increase problem-solving skills and offer social support through the use of web-based therapist facilitated sessions
Study NCT02364544 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Computer CBT for voices and paranoia
Description: A ten-session CBT programs, one to address voices and the other for paranoia. The web-based programs incorporate the essential elements of CBT for psychosis such as normalizing behavior and offering behavioral coping strategies
Study NCT02364544 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: FOCUS
Description: an interactive smart phone text-messaging application to support medication adherence, facilitate coping with symptoms and improve daily functioning in individuals with schizophrenia
Study NCT02364544 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Prescriber Decision Assistant
Description: is a web-based prescriber decision support system that includes a brief patient-completed assessment describing symptoms and adverse events which prompts the prescriber to conduct a detailed clinical assessment. Embedded in the program are decision supports for medication choices based on best evidence-based practices regarding symptoms, side effects, information from laboratory tests and history of prior treatment response
Study NCT00871039 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Patients to be sedated for up to 72 hours with study drug midazolam
Study NCT04008992 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986259
Description: Single and Multiple ascending dose from Dose 1 to Dose 5
Study NCT04008992 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo matching BMS-986259
Study NCT01924260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alisertib
Description: Given PO
Study NCT01924260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Description: Given IV
Study NCT01719627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maraviroc
Description: Unique dose of Maraviroc 300mg
Study NCT01719627 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TVD 300/200 QD
Description: TVD 300/200 QD during 7 days
Study NCT01719627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maraviroc
Description: Unique dose of Maraviroc 600mg
Study NCT04234282 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual Physical Therapy
Description: Orthopedic manual physical therapy targeting the knee joint and soft tissues with complementary exercises targeted at their impairment.
Study NCT02150954 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pitocin
Study NCT04375137 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Oxidative Stress ELISA Kit
Description: Checking oxidative stress markers and redox system status
Study NCT00390533 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saredutant
Description: oral administration (capsules)
Study NCT00390533 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oral administration (capsules)
Study NCT00751647 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Physical Therapy
Description: Treatment
Study NCT03585439 — intervention group
Intervention type: PROCEDURE
Intervention: Observational study evaluating the results of an intervention for isthmic spondylolisthesis: surgical procedure with double approach: Anterior lumbar Interbody Fusion then postero-lateral fusion
Description: First in supine position, an ALIF is performed: with a Pfannenstiel incision, through a retroperitoneal approach, a discectomy is performed at the level of the spondylolisthesis then a cage is placed between the two vertebral bodies. Then, in prone position, a standard posterior approach is performed, pedicle screws are placed to achieve a postero-lateral fusion. A decompression may be associated.
Study NCT03287804 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AUTO2
Description: AUTO2 (APRIL CAR T Cells) Following preconditioning with chemotherapy (cyclophosphamide and fludarabine) patients will be treated with doses from 15 x 10⁶ to 350 x 10⁶ APRIL CAR T Cells.~Following Phase 2 dose determination patients will be treated with selected dose of APRIL CAR T Cells
Study NCT01873001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone HCl
Description: 15 mg tablet administered by mouth on Day 1, and Day 8 1 hour after study drug administration
Study NCT01873001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate
Description: 1000 mg tablets administered by mouth on Day 8
Study NCT03698474 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Natrium picosulfate / Magnesium citrate
Description: bowel preparation formula
Study NCT03698474 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene glycol / Ascorbic acid
Description: bowel preparation formula
Study NCT03698474 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Natrium/ Kalium/ Magnesium sulfate
Description: bowel preparation formula
Study NCT06067542 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Surgery of impacted mandibular wisdom teeth
Description: All surgical procedures were performed by the same surgeon using the standard surgical technique described below. The anesthetic used was 4% articaine with 1:100,000 adrenaline. In all patients, a sulcus incision was made in the lower second molar and an envelope incision in the third molar region, the mucoperiosteal flap was removed, and extraction was performed with a bone elevator and a third molar elevator. If necessary, the impacted molar was incised with a high-speed dental handpiece and a fissure bur. The wound was irrigated with copious amounts of saline, and the wound edges were carefully sutured with simple 4.0 silk braided non-absorbable sutures.
Study NCT06067542 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery of impacted mandibular wisdom teeth
Description: All surgical procedures were performed by the same surgeon using the standard surgical technique described below. The anesthetic used was 4% articaine with 1:100,000 adrenaline. In all patients, a sulcus incision was made in the lower second molar and an envelope incision in the third molar region, the mucoperiosteal flap was removed, and extraction was performed with a bone elevator and a third molar elevator. If necessary, the impacted molar was incised with a high-speed dental handpiece and a fissure bur. The wound was irrigated with copious amounts of saline, and the wound edges were carefully sutured with simple 4.0 silk braided non-absorbable sutures.
Study NCT02204787 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Study NCT02204787 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Study NCT05153031 — intervention group
Intervention type: OTHER
Intervention: lithiasic
Description: Cholelithiasis is the presence of one or more calculi (gallstones) in the gallbladder.
Study NCT05153031 — intervention group
Intervention type: PROCEDURE
Intervention: Emergency surgery
Description: Emergency cholecystectomy
Study NCT05153031 — intervention group
Intervention type: PROCEDURE
Intervention: cholecystectomy
Description: cholecystectomy
Study NCT04065516 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ARAT technique
Description: After an initial endoscopic evaluation, ARAT technique will be performed with marking, submucosal elevation at esophagogastric junction and then ablation with 100-120w of 270-300 degrees at esophagogastric junction, once the application of the therapy is performed mucosal lavage and immersion technique will be made to corroborate integrity and continuity of the gastrointestinal tract and rule out immediate complications.
Study NCT02603380 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study. No intervention will be given.
Study NCT02599740 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Natural fruit extract
Description: Natural fruit extract consumed with rice
Study NCT02599740 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Assumed active
Description: Assumed key active consumed with rice
Study NCT02599740 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Rice only
Study NCT02283229 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Newborns with preventive caring advices
Description: Advices to prevent head molding
Study NCT02283229 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Newborns with normal caring advices
Description: Normal handling
Study NCT03671434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Research-to-Policy Collaboration
Description: The RPC is a behavioral intervention through which RPC Researchers and RPC Congressional Offices are prepared and matched for collaboration. Specifically, congressional offices are asked to identify opportunities for researcher engagement in policy efforts, researchers with expertise related to policy opportunities are identified and prepared to collaborate with congressional offices, researchers and congressional staff are matched for ongoing collaborative partnerships, and both researchers and congressional staff receive ongoing support to facilitate research translation.
Study NCT03671434 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Light Touch Policy Training
Description: Control Researchers are provided information on policy engagement via email.
Study NCT03359954 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study NCT03359954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo breast surgery
Study NCT02237703 — intervention group
Intervention type: OTHER
Intervention: Positron emission tomography (PET) imaging
Description: Positron emission tomography (PET) imaging
Study NCT01159236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 500 mg/m2 by vein given on day 1 and repeated once every 21 days for 4 treatments.
Study NCT01045330 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: a modified NTU-HELP
Description: The intervention consists of a daily inpatient care protocol on three core intervention protocols on top of hospital routine care.
Study NCT01159236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 10 mg/kg intravenously every 2 weeks, discontinued 6 weeks before surgery (i.e. after 3rd course of FEC or FAC)
Study NCT01338506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment with Prolonged Exposure (COPE)
Description: 12 weeks of concurrent prolonged exposure treatment for PTSD combined with cognitive behavioral therapy for substance use disorders (alcohol or drugs).
Study NCT01338506 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Concurrent Treatment with Prolonged Exposure (COPE)
Description: 12 weeks of concurrent prolonged exposure treatment for PTSD combined with cognitive behavioral therapy for substance use disorders (alcohol or drugs).
Study NCT00529204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: exenatide
Description: Subjects meeting the inclusion criteria will be treated with exenatide 5 µg BID s.c. for 3-7 days, followed by 10 µg BID s.c. daily to week 24
Study NCT03353961 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion regulation individual therapy
Description: The emotion regulation individual therapy is delivered via an internet platform and includes therapist contact several times per week via the platform.
Study NCT03353961 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as usual as provided in the community.
Study NCT02460406 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: traditional physiotherapy
Description: We are applying routine traditional physiotherapy consisted of neurodevelopmental treatment (stretching, weight bearing, functional reaching \& walking so on).
Study NCT02460406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: progressive functional strength training
Description: Participants allocated to the experimental group completed three times a week, 12-week progressive resistance training protocol. This protocol consisted of functional squat system with virtual reality in leg press, plyometric exercises, exercises with Bosu ball \& heel-rise exercises. This intensity of training is approximately equal to training at an intensity of 60% to 80% of one-repetition maximum according to National Strength and Conditioning Association (NSCA) protocols. Intensity of exercise is gradually increased 10% bi-weekly.
Study NCT02647385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Block with lidocaine for SAM and PEC I block
Description: Patients could be submitted to general anesthesia or general anesthesia associated with SAM and PEC I block with lidocaine before mastectomy.~Interventions: include pain assessment, inflammatory response and opioid consumption.
Study NCT01474993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulforaphane-rich Broccoli Sprout Extract
Description: 30 subjects will be randomly selected to receive sulforaphane-rich Broccoli Sprout Extract. The medication will be supplied and dispensed as No.1 size gelcaps (each gelcap containing \~ 250 mg sulforaphane rich Broccoli Sprout Extract, equivalent to \~ 50 µmol of sulforaphane). The dosage of sulforaphane will depend on subject's body weight:~1. Subjects with body weight less than 101 lbs will receive \~ 50 micromol sulforaphane per day (1 gelcap to be taken once a day)~2. Subjects with body weight 101 lbs to 199 lbs will receive \~ 100 micromol sulforaphane per day (2 gelcaps to be taken once a day)~3. Subjects with bidy weight > 199 lbs will receive \~ 150 micromol sulforaphane per day (3 gelcaps to be taken once a day)
Study NCT01474993 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 15 subjects will be randomly selected to receive inactive placebo (Gelcaps identical in appearance to that of active medication and containing microcrystalline cellulose)
Study NCT01924793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAS181-F02 Dry Powder in Bulk
Description: Administered via DPI
Study NCT01924793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DAS181-F02 Nebulized Formulation Inhaled Dose
Description: Administered via Nebulizer
Study NCT00650689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezetimibe + Atorvastatin
Description: oral tablets: ezetimibe 10 mg + atorvastatin 10 mg once daily for 6 weeks
Study NCT00650689 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin
Description: oral tablets: atorvastatin 10 mg + ezetimibe placebo once daily for 6 weeks
Study NCT01060410 — intervention group
Intervention type: GENETIC
Intervention: Polymorphism Analysis
Description: Analysis of genetic polymorphisms of the drug metabolic enzymes involving in the bio-activation and elimination of cyclophosphamide
Study NCT01060410 — intervention group
Intervention type: DRUG
Intervention: Cyclophosphamide
Description: intravenous injection, 0.2g, once every two days
Study NCT01060410 — intervention group
Intervention type: OTHER
Intervention: Pharmacokinetic analysis
Description: laboratory analysis of concentration of cyclophosphamide and 4-OH-cyclophosphamide in plasma
Study NCT01558791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TBI handout
Description: The intervention is an educational handout which covers key concepts found in the empirical literature and explicated in the VA/DoD mTBI practice guideline; (1) the meaning of a positive screen, (2) symptoms may be due to another condition, (3) most people with mTBI recover.
Study NCT01172340 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral and support intervention
Description: Individual counseling session with diet and exercise recommendations, 16 weekly group sessions, 8 weeks of followup phone support
Study NCT01172340 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Wait-listed control group
Description: Controls receive the same individual counseling session as intervention group; receive mailed health information; are offered group sessions after last post-measure
Study NCT03702166 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Processing Therapy (CPT)
Description: CPT is a cognitive behavioral treatment for PTSD consisting of 12 one-hour sessions. CPT is delivered in three phases: education, processing, and challenging.
Study NCT03952676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Moving cupping
Description: 1. We use a black opaque eye mask to shield the patient's eyes and choose different sizes of cup according to the location of the treatment (There are three sizes of cups)~2. (1) First apply Vaseline to the skin lesions area; (2) Then hold the 95% ethanol cotton ball with tweezers, and hold the cup with the facing down, after the cotton ball is ignited, immediately sway down in the cup and then exit, and quickly buckle the cup to the skin lesions area. (3) After using the cup to absorb the skin lesions area, hold the cup body in one hand and push and pull the cup along the certain route with a little strength, so that the skin purple color of the treatment area is suitable. (4) Apply even force when pushing the cup to prevent the cup from falling off due to air leakage. (5) Acting on the skin lesions area 30 times, change cup 5 times per push and pull, the interval is not more than 10 seconds.
Study NCT03952676 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Moving cupping placebo
Description: Using of special perforated cups, the manipulation method is the same as the intervention group.